144 ·Filed Jun 22, 2026
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral
Routine 10b5-1 plan sale by a director with no material signal. Monitor for future insider filings to detect any sustained selling pattern.
Final — all horizons settled through T+60d
RYTM ▼ -7.70% at T+60d
NEUTRAL call ✗ call lost -7.70% · α vs SPY -10.95% · entry $106.19 → $98.01
T+1d
+1.28%
call +1.28% · α +1.33%
$107.55
settled 3mo ago
T+5d
+3.63%
call +3.63% · α +2.61%
$110.04
settled 3mo ago
T+20d
-1.50%
call -1.50% · α -2.66%
$104.60
settled 2mo ago
T+60d
-7.70%
call -7.70% · α -10.95%
$98.01
settled 16d ago
Price Chart
Loading chart...
Executive Summary
Director Lynn Tetrault filed a Form 144 to sell 37,000 shares via option exercise, valued at approximately $3.58 million, under a 10b5-1 plan adopted on 12/15/2025. The sale is small relative to the company's $6.6B market cap and represents routine insider diversification with no material read-through for the stock.
Key Facts
- Director Lynn Tetrault intends to sell 37,000 shares of common stock.
- Estimated proceeds of $3,581,230 (based on filing price).
- Sale is pursuant to a 10b5-1 plan adopted on 12/15/2025.
- Sale date is 06/22/2026, same day as filing.
- Sale represents approximately 0.05% of RYTM's $6.6B market cap.
Financial Impact
Director sale of ~$3.58M; 0.05% of market cap.
Risk Factors
- Minimal — no material risk to stock from this filing alone.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
91% bullish (22 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006392 |
| Document: 0001950047-26-006392-index.html | 0001950047-26-006392 |
| Document: 0001950047-26-006392.txt | 0001950047-26-006392 |
18 reports for RYTM
67% Hit rate best @ T+60▲ +32.06%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 14, 2026 17d ago | 144 | $96.77 $99.27 | ▼ −2.58% | ▼ −0.47% | $93.68 (+3.19%) |
Aug 17, 2026 6w ago | Insider Cluster | $115.25 $113.35 | ▲ +1.65% | ▲ +1.45% | $93.68 (+18.72%) |
Aug 17, 2026 6w ago | Insider Cluster | $115.25 $113.35 | ▼ −1.65% | ▼ −1.45% | $93.68 (−18.72%) |
Aug 4, 2026 8w ago | 8-K | $105.78 $112.85 | ▲ +6.68% | ▲ +6.78% | $93.68 (−11.44%) |
Aug 4, 2026 8w ago | Press Release | $105.78 $112.85 | ▲ +6.68% | ▲ +6.78% | $93.68 (−11.44%) |
Jul 8, 2026 12w ago | Press Release | $115.48 $106.09 | ▼ −8.13% | ▼ −8.00% | $93.68 (−18.88%) |
Jun 22, 2026 14w ago | 144 | $106.19 $110.04 | ▲ +3.63% | ▲ +2.61% | $93.68 (−11.78%) |
Jun 15, 2026 15w ago | 8-K | $89.72 $106.19 | ▲ +18.36% | ▲ +20.59% | $93.68 (+4.41%) |
Jun 15, 2026 15w ago | Press Release | $89.72 $106.19 | ▲ +18.36% | ▲ +20.59% | $93.68 (+4.41%) |
Jun 13, 2026 15w ago | Press Release | $89.70 $101.39 | ▲ +13.03% | ▲ +14.42% | $93.68 (+4.44%) |
Showing 10 of 18
US Market Status
Market Open — Closes in 3h 55m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access